Around £45bn in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under the UK-US trade deal agreed last December […]
The EU drug watchdog, the European Medicines Agency (EMA), has given the green light for eight new medicines at its May meeting. This brings to 36 the number […]
The European Medicines Agency’s key human medicines committee (CHMP) has recommended five medicines for approval at its March 2026 meeting. This brings to 23 the total number of […]
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of […]
The European Medicines Agency (EMA) has recommended 14 new medicines for approval at its September meeting. The key Committee on Human Medicinal Products (CHMP) reviews safety and efficacy […]
The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP) […]
April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost […]
The European Medicines Agency (EMA) has recommended four new products for approval, and extended the use of sixteen other drugs. The decisions, which brings to 12 the total […]
The European Medicines Agency rounded off a busy year by approving seventeen new medicines. At its December meeting, the Committee for Medicinal Products for Human Use (CHMP) also […]
The European Medicines Agency has approved more than 100 new medicines for the first time in fifteen years. Of the 114 medicines given the green light in 2024, […]
Ten new medicines have been recommended for approval by the European Medicines Agency (EMA), with another six products recommended for extension of their therapeutic indications. This brings to […]
The European Medicines Agency (EMA) has approved fourteen new medicines at a summer meeting, with a further eleven products recommended for extension of therapeutic indications. The Agency’s human […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
